• 1
    Miller B, Schieffelbein C. Tuberculosis. Bull World Health Organ 1998;76: 1413.
  • 2
    Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990; 145: 14954.
  • 3
    Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993;178: 22437.
  • 4
    Jouanguy E, Doffinger R, Dupuis S, Pallier A, Altare F, Casanova JL. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999;11: 34651.
  • 5
    Nakamura K, Okamura H, Wada K, Nagata K, Komatsu T, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989;38: 5905.
  • 6
    Klein SA, Ottmann OG, Ballas K et al. Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction. Cytokine 1999;11: 4518.
  • 7
    Kohno K, Kataoka J, Ohtsuki T et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158: 154150.
  • 8
    Olee T, Hashimoto S, Quach J, Lotz M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999;162: 1096100.
  • 9
    Udagawa N, Horwood NJ, Elliott J et al. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 1997;185: 100512.
  • 10
    Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002;80: 14762.
  • 11
    Takeda K, Tsutsui H, Yoshimoto T et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8: 38390.
  • 12
    Dinarello CA, Novick D, Puren AJ et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998;63: 65864.
  • 13
    Bohn E, Sing A, Zumbihl R et al. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 1998;160: 299307.
  • 14
    Kawakami K, Qureshi MH, Zhang T, Okamura H, Kurimoto M, Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J Immunol 1997;159: 552834.
  • 15
    Ushio S, Namba M, Okura T et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156: 42749.
  • 16
    Ghayur T, Banerjee S, Hugunin M et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997;386: 61923.
  • 17
    Gu Y, Kuida K, Tsutsui H et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997;275: 2069.
  • 18
    Mastroeni P, Clare S, Khan S et al. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 1999;67: 47883.
  • 19
    Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 1999;67: 25859.
  • 20
    Wei XQ, Leung BP, Niedbala W et al. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol 1999;163: 28218.
  • 21
    Garcia VE, Uyemura K, Sieling PA et al. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 1999;162: 611421.
  • 22
    Vankayalapati R, Wizel B, Weis SE, Samten B, Girard WM, Barnes PF. Production of interleukin-18 in human tuberculosis. J Infect Dis 2000;182: 2349.
  • 23
    Song CH, Kim HJ, Park JK et al. Depressed IL-12, but not IL-18 production in response to a 30- and 32-kDa mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun 2000;68: 447784.
  • 24
    Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, Abe S. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med 2000;161: 17869.
  • 25
    Gerwin BI, Lechner JF. In vitro culture of differentiated human cells as models for study of oxidant injury. In: TMBray, NWSchoene, eds. Models and Methods in Cell Signalling and Gene Expression. London: OICA International (UK) Limited, 2000, 359.
  • 26
    Lee JS, Song CH, Kim CH et al. Profiles of IFN-γ and its regulatory cytokines (IL-12, IL-18, and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol2002;128: 51624.
  • 27
    Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998;70: 281312.
  • 28
    Meyer Zum Buschenfelde C, Cramer S, Trumpfheller C, Fleischer B, Frosch S. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production. Clin Exp Immunol 1997;110: 37885.
  • 29
    Monteforte GM, Takeda K, Rodriguez-Sosa M, Akira S, David JR, Satoskar AR. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J Immunol 2000;164: 58903.
  • 30
    Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999;162: 50707.
  • 31
    Robinson D, Shibuya K, Mui A et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997;7: 57181.
  • 32
    Stoll S, Jonuleit H, Schmitt E et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998;28: 32319.
  • 33
    Ferrer J. Pleural tuberculosis. Eur Respir J 1997;10: 9427.
  • 34
    Hua CC, Chang LC, Chen YC, Chang SC. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 1999;116: 12926.
  • 35
    Orphanidou D, Gaga M, Rasidakis A et al. Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion. Respir Med 1996;90: 958.
  • 36
    Hoheisel G, Izbicki G, Roth M et al. Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy. Respir Med 1998;92: 147.
  • 37
    Zhang M, Gately MK, Wang E et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93: 17339.
  • 38
    Ahn HJ, Maruo S, Tomura M et al. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ. J Immunol 1997;159: 212531.
  • 39
    Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer-zum-Buschenfelde KH, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promoter in primary CD4+ T lymphocytes. J Immunol 1998;160: 36427.
  • 40
    Nakahira M, Ahn HJ, Park WR et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 2002;168: 114653.
  • 41
    Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFN gamma-inducing factor) induces IL-8 and IL-1beta via TNF alpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998;101: 71121.
  • 42
    Nasreen N, Mohammed KA, Ward MJ, Antony VB. Mycobacterium-induced transmesothelial migration of monocytes into pleural space: role of intercellular adhesion molecule-1 in tuberculous pleurisy. J Infect Dis 1999;180: 161623.
  • 43
    Valdes L, Alvarez D, San Jose E et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Medical 1998; 158: 201721.
  • 44
    Vankayalapai R, Wizel B, Lakey DL et al. T Cells enhance production of IL-18 by monocytes in response to an intracellular pathogen. J Immunol 2001;166: 674953.